Home » Analyst Articles – US
Cognex (NASDAQ:CGNX) Stock Price Target Cut by Barclays
Cognex (NASDAQ:CGNX – Get Free Report) had its price target dropped by equities researchers at Barclays from $85.00 to $76.00 in a report released on Monday, Benzinga reports. The firm presently has an “overweight”... More of this article »
Oppenheimer Has Lowered Expectations for Alumis (NASDAQ:ALMS) Stock Price
Alumis (NASDAQ:ALMS – Get Free Report) had its price target dropped by Oppenheimer to $28.00 in a report released on Monday, Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Oppenheimer‘s... More of this article »
Ceva (NASDAQ:CEVA) Raised to Buy at Cfra
Ceva (NASDAQ:CEVA – Get Free Report) was upgraded by equities researchers at Cfra from a “hold” rating to a “buy” rating in a research note issued to investors on Monday, FinViz reports. Several other... More of this article »
Benitec Biopharma (NASDAQ:BNTC) Stock Price Expected to Rise, Wedbush Analyst Says
Benitec Biopharma (NASDAQ:BNTC – Get Free Report) had its price target upped by equities research analysts at Wedbush from $17.00 to $20.00 in a research note issued on Monday, MarketBeat.com reports. The firm presently has... More of this article »
JPMorgan Chase & Co. Issues Pessimistic Forecast for KANZHUN (NASDAQ:BZ) Stock Price
KANZHUN (NASDAQ:BZ – Get Free Report) had its target price reduced by stock analysts at JPMorgan Chase & Co. from $22.00 to $18.00 in a research note issued on Monday, Benzinga reports. The firm currently has an “overweight”... More of this article »
Bit Digital (NASDAQ:BTBT) Stock Price Target Cut by B. Riley Financial
Bit Digital (NASDAQ:BTBT – Get Free Report) had its price objective lowered by analysts at B. Riley Financial to $3.50 in a report released on Monday, Benzinga reports. The brokerage presently has a “buy” rating... More of this article »
Guggenheim Has Lowered Expectations for ArriVent BioPharma (NASDAQ:AVBP) Stock Price
ArriVent BioPharma (NASDAQ:AVBP – Get Free Report) had its target price lowered by Guggenheim from $30.00 to $28.00 in a research report issued on Monday, MarketBeat Ratings reports. The brokerage presently has a “buy”... More of this article »
Citigroup Issues Pessimistic Forecast for Candel Therapeutics (NASDAQ:CADL) Stock Price
Candel Therapeutics (NASDAQ:CADL – Get Free Report) had its price objective decreased by analysts at Citigroup from $26.00 to $20.00 in a report released on Monday, Benzinga reports. The firm presently has a “buy”... More of this article »
CDW (NASDAQ:CDW) Stock Price Expected to Rise, Barclays Analyst Says
CDW (NASDAQ:CDW – Get Free Report) had its target price boosted by equities research analysts at Barclays from $148.00 to $164.00 in a report released on Monday, Benzinga reports. The brokerage currently has an “equal... More of this article »
Airbnb (NASDAQ:ABNB) Raised to “Hold” at Phillip Securities
Airbnb (NASDAQ:ABNB – Get Free Report) was upgraded by research analysts at Phillip Securities from a “moderate sell” rating to a “hold” rating in a report released on Monday, MarketBeat Ratings reports.... More of this article »
Atea Pharmaceuticals (NASDAQ:AVIR) Stock Price Expected to Rise, Morgan Stanley Analyst Says
Atea Pharmaceuticals (NASDAQ:AVIR – Get Free Report) had its target price lifted by stock analysts at Morgan Stanley from $7.00 to $8.00 in a note issued to investors on Monday, Benzinga reports. The firm presently has an “equal... More of this article »
Codexis (NASDAQ:CDXS) Earns Overweight Rating from Stephens
Codexis (NASDAQ:CDXS – Get Free Report)‘s stock had its “overweight” rating reaffirmed by analysts at Stephens in a research report issued to clients and investors on Monday, Benzinga reports. They currently... More of this article »
Belite Bio (NASDAQ:BLTE) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says
Belite Bio (NASDAQ:BLTE – Get Free Report) had its price objective increased by Canaccord Genuity Group from $303.00 to $314.00 in a research note issued on Monday, Benzinga reports. The brokerage presently has a “buy”... More of this article »
Absci (NASDAQ:ABSI) Stock Price Target Cut by Guggenheim
Absci (NASDAQ:ABSI – Get Free Report) had its price objective reduced by equities researchers at Guggenheim from $15.00 to $14.00 in a research note issued to investors on Monday, MarketBeat reports. The brokerage currently... More of this article »
Cogent Communications (NASDAQ:CCOI) Stock Gets Downgrade from Wells Fargo & Company
Cogent Communications (NASDAQ:CCOI – Get Free Report) was downgraded by analysts at Wells Fargo & Company from an “equal weight” rating to an “underweight” rating in a report issued on Monday, Marketbeat... More of this article »
Freedom Broker Has Lowered Expectations for Applied Materials (NASDAQ:AMAT) Stock Price
Applied Materials (NASDAQ:AMAT – Get Free Report) had its price objective cut by Freedom Broker from $530.00 to $490.00 in a report issued on Monday, MarketBeat reports. The brokerage presently has a “buy” rating... More of this article »
Piper Sandler Forecasts Strong Price Appreciation for AbCellera Biologics (NASDAQ:ABCL) Stock
AbCellera Biologics (NASDAQ:ABCL – Get Free Report) had its target price hoisted by equities research analysts at Piper Sandler from $12.00 to $20.00 in a research report issued on Monday, Benzinga reports. The firm currently... More of this article »
Avalyn Pharma (NASDAQ:AVLN) Stock Price Target Cut by Morgan Stanley
Avalyn Pharma (NASDAQ:AVLN – Get Free Report) had its price target decreased by Morgan Stanley from $57.00 to $53.00 in a note issued to investors on Monday, Benzinga reports. The brokerage currently has an “overweight”... More of this article »
argenex (NASDAQ:ARGX) Stock Gets Price Target Bump from Piper Sandler
argenex (NASDAQ:ARGX – Get Free Report) had its price objective raised by equities researchers at Piper Sandler from $1,215.00 to $1,350.00 in a report issued on Monday, Benzinga reports. The firm presently has an “overweight”... More of this article »
Royal Bank Of Canada Forecasts Strong Price Appreciation for Aetherion Technologies (NASDAQ:AETR) Stock
Aetherion Technologies (NASDAQ:AETR – Get Free Report) had its price objective lifted by research analysts at Royal Bank Of Canada from $1.00 to $1.75 in a research report issued to clients and investors on Monday, Benzinga... More of this article »
Costco Wholesale (NASDAQ:COST) Stock Gets Downgrade from Northcoast Research
Costco Wholesale (NASDAQ:COST – Get Free Report) was downgraded by equities research analysts at Northcoast Research from a “buy” rating to a “neutral” rating in a research note issued on Monday, MarketBeat... More of this article »
Corsair Gaming (NASDAQ:CRSR) Stock Gets Price Target Increase from Wedbush
Corsair Gaming (NASDAQ:CRSR – Get Free Report) had its price target hoisted by research analysts at Wedbush from $16.00 to $17.00 in a research report issued to clients and investors on Monday, Benzinga reports. The brokerage... More of this article »
Benitec Biopharma (NASDAQ:BNTC) Stock Gets Price Target Bump from Leerink Partners
Benitec Biopharma (NASDAQ:BNTC – Get Free Report) had its price target lifted by equities research analysts at Leerink Partners from $18.00 to $18.27 in a report released on Monday, Benzinga reports. The firm presently has an... More of this article »
